Concepedia

Shi-Zhe Zhang

SZ

Statistics

Publications

6

Citations

464

H-Index

6

Active since

2018

Affiliations

Fudan University(Current)

Zhongshan Hospital

Ministry of Education

Ministry of Education of the People's Republic of China

Second Military Medical University

Shi-Zhe Zhang is an author at Fudan University specializing in oncology, medicine, and hepatocellular carcinoma pathogenesis.

Publications per year

2018–2021

6

Publications

6

miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a

Manqing Cao, A‐Bin You, Xiao‐Dong Zhu et al. · Journal of Hematology & Oncology · 2018 · 241 citations · Full text

, , +17

PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma

Shi-Zhe Zhang, Xiao‐Dong Zhu, Long-Hai Feng et al. · Experimental Hematology and Oncology · 2021 · 97 citations · Full text

, , +17

NT5DC2 promotes tumor cell proliferation by stabilizing EGFR in hepatocellular carcinoma

Kangshuai Li, Xiao‐Dong Zhu, Hongda Liu et al. · Cell Death and Disease · 2020 · 59 citations · Full text

, , +17

The Rho GTPase Rnd1 inhibits epithelial–mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target

Chengdong Qin, De-Ning Ma, Shi-Zhe Zhang et al. · Cell Death and Disease · 2018 · 38 citations · Full text

, , +17

Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma

Long-Hai Feng, Hui‐Chuan Sun, Xiao‐Dong Zhu et al. · Annals of Translational Medicine · 2021 · 17 citations · Full text

, , +17

1–5 of 6